<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04493424</url>
  </required_header>
  <id_info>
    <org_study_id>1368-0024</org_study_id>
    <secondary_id>2020-000189-41</secondary_id>
    <nct_id>NCT04493424</nct_id>
  </id_info>
  <brief_title>A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab</brief_title>
  <official_title>An Open-label, Long Term Safety Trial of Spesolimab Treatment in Patients With Palmoplantar Pustulosis (PPP) Who Have Completed Previous BI Spesolimab Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is open to people with palmoplantar pustulosis who took part in previous clinical&#xD;
      studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment&#xD;
      in the previous studies can join this study.&#xD;
&#xD;
      The purpose of this study is to find out how safe spesolimab is and whether it helps people&#xD;
      with palmoplantar pustulosis in the long-term. Participants are in this study for up to 5&#xD;
      years. During this time they visit the study site every month to get spesolimab injections&#xD;
      under the skin.&#xD;
&#xD;
      At study visits, doctors check the severity of participants' palmoplantar pustulosis and&#xD;
      collect information on any health problems of the participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 4, 2020</start_date>
  <completion_date type="Anticipated">July 25, 2029</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2029</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of treatment emergent adverse events (TEAEs)</measure>
    <time_frame>Up to week 260</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent change in Palmoplantar Pustulosis Area and Severity Index (PPP ASI) from baseline in parent trial</measure>
    <time_frame>Up to week 260</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Palmoplantar Pustulosis Area and Severity Index 50% (PPP ASI50) compared to baseline in parent trial</measure>
    <time_frame>Up to week 260</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with Palmoplantar Pustulosis Physician Global Assessment (PPP PGA) of 0 (clear) or 1 (almost clear)</measure>
    <time_frame>Up to week 260</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Palmoplantar Pustulosis</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to 260 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spesolimab</intervention_name>
    <description>Spesolimab</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed and dated written informed consent for the current trial 1368-0024, in&#xD;
             accordance with ICH-GCP and local legislation prior to admission to the current trial&#xD;
&#xD;
          -  Male or female patients who have completed the treatment period in one of the parent&#xD;
             trials without premature discontinuation&#xD;
&#xD;
          -  Patients who have obtained an individual health benefit, per investigator judgement&#xD;
             (e.g. PPP PGA of 0 (clear) or 1 (almost clear) or other clinical improvement), from&#xD;
             treatment in the parent trial&#xD;
&#xD;
          -  Women of childbearing potential must be ready and able to use highly effective methods&#xD;
             of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per&#xD;
             year when used consistently and correctly&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are pregnant, nursing, or who plan to become pregnant while in the trial&#xD;
&#xD;
          -  Patients who experienced study treatment-limiting adverse events during the parent&#xD;
             trial&#xD;
&#xD;
          -  Severe, progressive, or uncontrolled condition such as renal, hepatic, haematological,&#xD;
             endocrine, pulmonary, cardiac, neurologic, cerebral, or psychiatric disease, or signs&#xD;
             and symptoms thereof&#xD;
&#xD;
          -  Patients with congestive heart disease, as assessed by the investigator&#xD;
&#xD;
          -  Patient with a transplanted organ (with exception of a corneal transplant &gt; 12 weeks&#xD;
             prior to screening in parent trial) or who have ever received stem cell therapy (e.g.,&#xD;
             Prochymal)&#xD;
&#xD;
          -  Known history of lymphoproliferative disease, including lymphoma, or signs and&#xD;
             symptoms suggestive of possible lymphoproliferative disease (e.g. splenomegaly)&#xD;
&#xD;
          -  Any documented active or suspected malignancy or history of malignancy at screening,&#xD;
             except appropriately treated basal cell carcinoma of the skin, squamous cell carcinoma&#xD;
             of the skin or in situ carcinoma of uterine cervix&#xD;
&#xD;
          -  Patients who have developed active or severe infective disease and opportunistic&#xD;
             infections/infective diseases&#xD;
&#xD;
          -  Further exclusion criteria apply&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boehringer Ingelheim</last_name>
    <phone>1-800-243-0127</phone>
    <email>clintriage.rdg@boehringer-ingelheim.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Total Skin and Beauty Dermatology Center, PC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Krell</last_name>
      <phone>+001(205)933-0987</phone>
      <email>jkrellmd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri Health System</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Braudis</last_name>
      <phone>+001(573)882-8030</phone>
      <email>braudiskm@health.missouri.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Psoriasis Treatment Center of Central New Jersey</name>
      <address>
        <city>East Windsor</city>
        <state>New Jersey</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jerry Bagel</last_name>
      <phone>+001(609)443-4500-x1402</phone>
      <email>dreamacres1@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Ferris</last_name>
      <phone>+001(412)647-2013</phone>
      <email>ferrislk@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Menter Dermatology Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Menter</last_name>
      <phone>+001(972)354-7993</phone>
      <email>alanmresearch@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah Health</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Callis Duffin</last_name>
      <phone>+001(801)213-0375</phone>
      <email>kristina.duffin@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Woden Dermatology</name>
      <address>
        <city>Phillip</city>
        <state>Australian Capital Territory</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Rubel</last_name>
      <phone>+61262828410</phone>
      <email>Diana@wodendermatology.com.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Fernandez-Penas</last_name>
      <phone>61288909767</phone>
      <email>pablo.fernandezpenas@sydney.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skin Health Institute Inc</name>
      <address>
        <city>Carlton</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Foley</last_name>
      <phone>+61396239400</phone>
      <email>pfoley@skincancer.asn.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Kern</last_name>
      <phone>61393424531</phone>
      <email>Johannes.Kern@mh.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brussels - UNIV Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Dominique Ghislain</last_name>
      <phone>+32(0)27641472</phone>
      <email>pierre-dominique.ghislain@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Hillary</last_name>
      <phone>+3216337950</phone>
      <email>tom.hillary@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Irina Turchin PC Inc.</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Turchin</last_name>
      <phone>506-459-1808</phone>
      <email>iturchin.bdc@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SimcoDerm Medical and Surgical Dermatology Centre</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryam Alam</last_name>
      <phone>705503-6331</phone>
      <email>alam@simcoderm.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Guenther Dermatology Research Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyn Guenther</last_name>
      <phone>519-435-0127</phone>
      <email>dgue@guentherMPC.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Innovaderm Research Inc.</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Bissonnette</last_name>
      <phone>514-521-3111</phone>
      <email>pirbissonnette@innovaderm.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCBR Czech a.s.</name>
      <address>
        <city>Pardubice</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaroslava Vaneckova</last_name>
      <phone>+420774477460</phone>
      <email>vanecjar@seznam.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanatorium Prof. Arenebergera</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Arenberger</last_name>
      <phone>+420602214443</phone>
      <email>avemedica@email.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOP l'Archet</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Passeron</last_name>
      <phone>+33(0)492039224</phone>
      <email>thierry.passeron@unice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOP Saint-Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé Bachelez</last_name>
      <phone>+33(0)142499817</phone>
      <email>herve.bachelez@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOP Larrey</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Polina Konstantinou</last_name>
      <phone>+33(0)567771408</phone>
      <email>konstantinou.mp@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgios Kokolakis</last_name>
      <phone>+49(30)450618333</phone>
      <email>georgios.kokolakis@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sticherling</last_name>
      <phone>+49(9131)8533851</phone>
      <email>Michael.Sticherling@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Pinter</last_name>
      <phone>+49(69)63015418</phone>
      <email>Andreas.Pinter@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Knut Schäkel</last_name>
      <phone>+49(6221)568511</phone>
      <email>knut.schaekel@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sascha Gerdes</last_name>
      <phone>+49(431)50021234</phone>
      <email>sgerdes@dermatology.uni-kiel.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pecs</name>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolland Gyulai</last_name>
      <phone>+3672536882</phone>
      <email>gyulai.rolland@pte.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Markusovszky University Teaching Hospital</name>
      <address>
        <city>Szombathely</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eniko Telegdy</last_name>
      <phone>+36943115425671</phone>
      <email>telegdyeniko@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fujita Health University Hospital</name>
      <address>
        <city>Aichi, Toyoake</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazumitsu Sugiura</last_name>
      <phone>+81562932111</phone>
      <email>kazumitsusugiura@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Dental College Ichikawa General Hospital</name>
      <address>
        <city>Chiba, Ichikawa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michiyoshi Kono</last_name>
      <phone>+81473220151</phone>
      <email>mkouno@tdc.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fukuoka University Hospital</name>
      <address>
        <city>Fukuoka, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shinichi Imafuku</last_name>
      <phone>+81928011011</phone>
      <email>simafuku.chiken@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gifu University Hospital</name>
      <address>
        <city>Gifu, Gifu</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoko Mizutani</last_name>
      <phone>+81582306000</phone>
      <email>watervalleyyoko@yahoo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asahikawa Medical University Hospital</name>
      <address>
        <city>Hokkaido, Asahikawa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mari Kishibe</last_name>
      <phone>+81166-65-2111</phone>
      <email>mkishibe@asahikawa-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Takagi Dermatological Clinic</name>
      <address>
        <city>Hokkaido, Obihiro</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hidetoshi Takahashi</last_name>
      <phone>+81155256733</phone>
      <email>htakahashi@cpost.plala.or.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Takamatsu Red Cross Hospital</name>
      <address>
        <city>Kagawa, Takamatsu</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshihisa Hamada</last_name>
      <phone>+81878317101</phone>
      <email>hamada-toshihisa@takamatsu.jrc.or.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sagamihara National Hospital</name>
      <address>
        <city>Kanagawa, Sagamihara</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanako Omatsu</last_name>
      <phone>042-742-8311</phone>
      <email>omatsu.hanako.vz@mail.hosp.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kumamoto University Hospital</name>
      <address>
        <city>Kumamoto, Kumamoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ikko Kajihara</last_name>
      <phone>+81963442111</phone>
      <email>kajiderma@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Kyoto Prefectural University of Medicine</name>
      <address>
        <city>Kyoto, Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norito Kato</last_name>
      <phone>+81752515111</phone>
      <email>nkatoh@koto.kpu-m.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tohoku University Hospital</name>
      <address>
        <city>Miyagi, Sendai</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenshi Yamasaki</last_name>
      <phone>+81227177000</phone>
      <email>kyamasaki@med.tohoku.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shinshu University Hospital</name>
      <address>
        <city>Nagano, Matsumoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eisaku Ogawa</last_name>
      <phone>+81263354600</phone>
      <email>ukasie@shinshu-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Okayama University Hospital</name>
      <address>
        <city>Okayama, Okayama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shin Morizane</last_name>
      <phone>+81862237151</phone>
      <email>zanemori@cc.okayama-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of the Ryukyus Hospital</name>
      <address>
        <city>Okinawa, Nakagami-gun</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takuya Miyagi</last_name>
      <phone>+81988953331</phone>
      <email>miya_skywalker2008@yahoo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nakatsu Dermatology Clinic</name>
      <address>
        <city>Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ichiro Katayama</last_name>
      <phone>+81663725640</phone>
      <email>espaikoffice@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka City University Hospital</name>
      <address>
        <city>Osaka, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiharu Tateishi</last_name>
      <phone>+81666452121</phone>
      <email>tatechiharu@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka University Hospital</name>
      <address>
        <city>Osaka, Suita</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yukinobu Nakagawa</last_name>
      <phone>+81668795111</phone>
      <email>nakagawa@derma.med.osaka-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shiga University of Medical Science Hospital</name>
      <address>
        <city>Shiga, Otsu</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takeshi Kato</last_name>
      <phone>+81775482111</phone>
      <email>kihsekat@belle.shiga-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jichi Medical University Hospital</name>
      <address>
        <city>Tochigi, Shimotsuke</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayumi Komine</last_name>
      <phone>+81285442111</phone>
      <email>mkomine12@jichi.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nihon University Itabashi Hospital</name>
      <address>
        <city>Tokyo, Itabashi-ku</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hideki Fujita</last_name>
      <phone>+81339728111</phone>
      <email>hfuji-tky@umin.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teikyo University Hospital</name>
      <address>
        <city>Tokyo, Itabashi-ku</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yayoi Tada</last_name>
      <phone>+81339641211</phone>
      <email>tada@df6.so-net.ne.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical University Hospital</name>
      <address>
        <city>Tokyo, Shinjuku-ku</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yukari Okubo</last_name>
      <phone>+81333426111</phone>
      <email>yukari-o@tokyo-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wakayama Medical University Hospital</name>
      <address>
        <city>Wakayama, Wakayama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masatoshi Jinnin</last_name>
      <phone>+81734472300</phone>
      <email>mjin@wakayama-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Medical Center</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JooYoung Roh</last_name>
      <phone>82324602763</phone>
      <email>jyroh1@gilhospital.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Woong Youn</last_name>
      <phone>82317877312</phone>
      <email>swyoun@snu.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seong-Jin Jo</last_name>
      <phone>82512407338</phone>
      <email>ayin76@hanmail.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barbara Rewerska Diamond Clinic, Krakow</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Rewerska</last_name>
      <phone>+48696049029</phone>
      <email>barbara@diamondclinic.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermoklinika medical center, Lodz</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksandra Lesiak</last_name>
      <phone>+48422309657,+48609279389</phone>
      <email>lesiak_ola@interia.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Independent Public Clin.Hosp.no1 Lublin</name>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorota Krasowska</last_name>
      <phone>+48815349677,+48608098578</phone>
      <email>dor.krasowska@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Municipal Hospital Complex in Olsztyn</name>
      <address>
        <city>Olsztyn</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waldemar Placek</last_name>
      <phone>+48896786654</phone>
      <email>w.placek@wp.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermmedica Sp. z o.o., Wroclaw</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jolanta Weglowska</last_name>
      <phone>+48713253446,+48501425260</phone>
      <email>jolaweglowska@tlen.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SBHI Chelyabinsk Reg.Clin.Derma.Dispen.</name>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oleg Ziganshin</last_name>
      <phone>+73512320093</phone>
      <email>ziganshin_oleg@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LLC &quot;Medical Center Azbuka Zdorovia&quot;</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bulat Khalilov</last_name>
      <phone>+78435280206</phone>
      <email>bvh099@rambler.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermatovenereological Dispensary #10, St. Petersburg</name>
      <address>
        <city>Saint-Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexey Sukharev</last_name>
      <phone>+78123297168</phone>
      <email>asoukharev@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsen Fang Tsai</last_name>
      <phone>886972651561</phone>
      <email>tftsai@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Devon and Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily McGrath</last_name>
      <phone>01392411611</phone>
      <email>Emily.mcgrath@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Pink</last_name>
      <phone>02071887188</phone>
      <email>Andrew.Pink@gstt.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://mystudywindow.com</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 28, 2020</study_first_submitted>
  <study_first_submitted_qc>July 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2020</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After the study is completed and the primary manuscript is accepted for publishing, researchers can use this following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed &quot;Document Sharing Agreement&quot;.&#xD;
Also, Researchers can use the following link https://www.mystudywindow.com/msw/datasharing to find information in order to request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.&#xD;
The data shared are the raw clinical study data sets.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.</ipd_time_frame>
    <ipd_access_criteria>For study documents - upon signing of a 'Document Sharing Agreement'. For study data - 1. after the submission and approval of the research proposal (checks will be performed by both the independent review panel and the sponsor, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a 'Data Sharing Agreement'.</ipd_access_criteria>
    <ipd_url>https://www.mystudywindow.com/msw/datasharing</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

